297 related articles for article (PubMed ID: 28951521)
1. Isoflurane promotes glucose metabolism through up-regulation of
Guo NL; Zhang JX; Wu JP; Xu YH
Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 28951521
[TBL] [Abstract][Full Text] [Related]
2. Ginsenoside 20(S)-Rg3 Inhibits the Warburg Effect Via Modulating DNMT3A/ MiR-532-3p/HK2 Pathway in Ovarian Cancer Cells.
Zhou Y; Zheng X; Lu J; Chen W; Li X; Zhao L
Cell Physiol Biochem; 2018; 45(6):2548-2559. PubMed ID: 29558748
[TBL] [Abstract][Full Text] [Related]
3. Overcoming cisplatin resistance of ovarian cancer cells by targeting HIF-1-regulated cancer metabolism.
Ai Z; Lu Y; Qiu S; Fan Z
Cancer Lett; 2016 Apr; 373(1):36-44. PubMed ID: 26801746
[TBL] [Abstract][Full Text] [Related]
4. Probing Metabolic Changes in IFNγ-Treated Ovarian Cancer Cells.
Kaur P; Nagar S; Bhagwat M; Uddin MM; Zhu Y; Vancura A
Methods Mol Biol; 2020; 2108():197-207. PubMed ID: 31939182
[TBL] [Abstract][Full Text] [Related]
5. Tumor cells switch to mitochondrial oxidative phosphorylation under radiation via mTOR-mediated hexokinase II inhibition--a Warburg-reversing effect.
Lu CL; Qin L; Liu HC; Candas D; Fan M; Li JJ
PLoS One; 2015; 10(3):e0121046. PubMed ID: 25807077
[TBL] [Abstract][Full Text] [Related]
6. Manipulation of tumor metabolism for therapeutic approaches: ovarian cancer-derived cell lines as a model system.
Goetze K; Fabian CG; Siebers A; Binz L; Faber D; Indraccolo S; Nardo G; Sattler UG; Mueller-Klieser W
Cell Oncol (Dordr); 2015 Oct; 38(5):377-85. PubMed ID: 26288178
[TBL] [Abstract][Full Text] [Related]
7. Cryptotanshinone suppresses ovarian cancer via simultaneous inhibition of glycolysis and oxidative phosphorylation.
Wang T; Zhang M; Khan M; Li J; Wu X; Ma T; Li Y
Biomed Pharmacother; 2024 Jan; 170():115956. PubMed ID: 38039759
[TBL] [Abstract][Full Text] [Related]
8. PTTG regulates the metabolic switch of ovarian cancer cells via the c-myc pathway.
Wang X; Duan W; Li X; Liu J; Li D; Ye L; Qian L; Yang A; Xu Q; Liu H; Fu Q; Wu E; Ma Q; Shen X
Oncotarget; 2015 Dec; 6(38):40959-69. PubMed ID: 26516926
[TBL] [Abstract][Full Text] [Related]
9. Ochratoxin A induces reprogramming of glucose metabolism by switching energy metabolism from oxidative phosphorylation to glycolysis in human gastric epithelium GES-1 cells in vitro.
Wang Y; Zhao M; Cui J; Wu X; Li Y; Wu W; Zhang X
Toxicol Lett; 2020 Oct; 333():232-241. PubMed ID: 32835834
[TBL] [Abstract][Full Text] [Related]
10. "Metabolic reprogramming" in ovarian cancer cells resistant to cisplatin.
Montopoli M; Bellanda M; Lonardoni F; Ragazzi E; Dorigo P; Froldi G; Mammi S; Caparrotta L
Curr Cancer Drug Targets; 2011 Feb; 11(2):226-35. PubMed ID: 21158717
[TBL] [Abstract][Full Text] [Related]
11. Cyclophilin D Modulates the Cardiac Mitochondrial Target of Isoflurane, Sevoflurane, and Desflurane.
Harisseh R; Chiari P; Villedieu C; Sueur P; Abrial M; Fellahi JL; Ovize M; Gharib A
J Cardiovasc Pharmacol; 2017 May; 69(5):326-334. PubMed ID: 28328748
[TBL] [Abstract][Full Text] [Related]
12. Atorvastatin protects the proliferative ability of human umbilical vein endothelial cells inhibited by angiotensin II by changing mitochondrial energy metabolism.
Chang Y; Li Y; Ye N; Guo X; Li Z; Sun G; Sun Y
Int J Mol Med; 2018 Jan; 41(1):33-42. PubMed ID: 29115384
[TBL] [Abstract][Full Text] [Related]
13. Gene regulatory networking reveals the molecular cue to lysophosphatidic acid-induced metabolic adaptations in ovarian cancer cells.
Ray U; Roy Chowdhury S; Vasudevan M; Bankar K; Roychoudhury S; Roy SS
Mol Oncol; 2017 May; 11(5):491-516. PubMed ID: 28236660
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-144 mediates metabolic shift in ovarian cancer cells by directly targeting Glut1.
Fan JY; Yang Y; Xie JY; Lu YL; Shi K; Huang YQ
Tumour Biol; 2016 May; 37(5):6855-60. PubMed ID: 26662316
[TBL] [Abstract][Full Text] [Related]
15. A Novel Methodology for Bioenergetic Analysis of Plasmodium falciparum Reveals a Glucose-Regulated Metabolic Shift and Enables Mode of Action Analyses of Mitochondrial Inhibitors.
Sakata-Kato T; Wirth DF
ACS Infect Dis; 2016 Dec; 2(12):903-916. PubMed ID: 27718558
[TBL] [Abstract][Full Text] [Related]
16. Availability of the key metabolic substrates dictates the respiratory response of cancer cells to the mitochondrial uncoupling.
Zhdanov AV; Waters AH; Golubeva AV; Dmitriev RI; Papkovsky DB
Biochim Biophys Acta; 2014 Jan; 1837(1):51-62. PubMed ID: 23891695
[TBL] [Abstract][Full Text] [Related]
17. The mitochondria-targeted imidazole substituted oleic acid 'TPP-IOA' affects mitochondrial bioenergetics and its protective efficacy in cells is influenced by cellular dependence on aerobic metabolism.
Maddalena LA; Ghelfi M; Atkinson J; Stuart JA
Biochim Biophys Acta Bioenerg; 2017 Jan; 1858(1):73-85. PubMed ID: 27836699
[TBL] [Abstract][Full Text] [Related]
18. Metabolic reprogramming and AMPKα1 pathway activation by caulerpin in colorectal cancer cells.
Yu H; Zhang H; Dong M; Wu Z; Shen Z; Xie Y; Kong Z; Dai X; Xu B
Int J Oncol; 2017 Jan; 50(1):161-172. PubMed ID: 27922662
[TBL] [Abstract][Full Text] [Related]
19. Molecular Pathways: Targeting Cellular Energy Metabolism in Cancer via Inhibition of SLC2A1 and LDHA.
Ooi AT; Gomperts BN
Clin Cancer Res; 2015 Jun; 21(11):2440-4. PubMed ID: 25838393
[TBL] [Abstract][Full Text] [Related]
20. PGC1α regulates mitochondrial oxidative phosphorylation involved in cisplatin resistance in ovarian cancer cells via nucleo-mitochondrial transcriptional feedback.
Shen L; Zhou L; Xia M; Lin N; Ma J; Dong D; Sun L
Exp Cell Res; 2021 Jan; 398(1):112369. PubMed ID: 33220258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
